These findings strongly suggest that AHI-1 may cooperate with BIN1 in the loss of its tumor suppressor activity through its interacting oncoprotein MYC to mediate cellular proliferation and apoptosis control of human CTCL cells and drive human CTCL pathogenesis. The gene discussed is AHI1; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.